MyoKardia, Inc. (MYOK): Price and Financial Metrics


MyoKardia, Inc. (MYOK)

Today's Latest Price: $65.88 USD

0.97 (-1.45%)

Updated Dec 11 6:55pm

Add MYOK to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

MYOK Stock Summary

  • With a price/sales ratio of 219.61, MyoKardia Inc has a higher such ratio than 98.86% of stocks in our set.
  • In terms of twelve month growth in earnings before interest and taxes, MyoKardia Inc is reporting a growth rate of 292.69%; that's higher than 95.78% of US stocks.
  • Revenue growth over the past 12 months for MyoKardia Inc comes in at -53.7%, a number that bests only 3.09% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to MyoKardia Inc are TRVN, KIN, MNTA, ONCE, and BPMX.
  • MYOK's SEC filings can be seen here. And to visit MyoKardia Inc's official web site, go to www.myokardia.com.
MYOK Daily Price Range
MYOK 52-Week Price Range

MYOK Stock Price Chart More Charts


MYOK Price/Volume Stats

Current price $65.88 52-week high $68.60
Prev. close $66.85 52-week low $39.01
Day low $65.03 Volume 193,100
Day high $67.20 Avg. volume 423,303
50-day MA $58.34 Dividend yield N/A
200-day MA $52.90 Market Cap 3.05B

MyoKardia, Inc. (MYOK) Company Bio


MyoKardia is a clinical stage biopharmaceutical company pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and neglected rare cardiovascular diseases





MYOK Latest News Stream


Event/Time News Detail
Loading, please wait...

MYOK Latest Social Stream


Loading social stream, please wait...

View Full MYOK Social Stream

MYOK Price Returns

1-mo 20.90%
3-mo 22.07%
6-mo 42.54%
1-year 17.90%
3-year 365.58%
5-year N/A
YTD 34.83%
2018 16.06%
2017 225.10%
2016 -11.66%
2015 N/A
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5301 seconds.